Section: Module 3: Lesson 3: Additional Testing | COVID-19 Orientation for Frontline Healthcare Providers in the Acute Care Setting | NextGenU.org

  • Patients who test positive for COVID-19 will require additional diagnostic testing to guide their treatment plan. 

    Learning objectives:
    • Understand conceptual aspects of the relationship between clinical signs and critical COVID-19 illness.
    Approximate time required for the readings for this lesson (at 144 words/minute): 35 mins

    Click here to start this lesson

    • The following contains information from the field.

      CT may show lung findings (such as ground-glass opacities) before the development of symptoms. In a setting of pandemic, assume that COVID-19 is the cause until proven otherwise, even if a patient is not symptomatic with COVID-specific symptoms. Ferritin, elevated IL-6 levels, C-reactive protein (CRP), d-dimer can be related to COVID-19 severe infection.

      Procalcitonin and prolactin are elevated in patients with bacterial co-infection. White blood cell (WBC) count is normal or low in COVID-19-only patients but sometimes elevated in patients with co-infection. (Auwaerter, 2020).

      References

      Auwaerter, P. G. (2020). Coronavirus COVID-19 (SARS-CoV-2). In Johns Hopkins ABX Guide. The Johns Hopkins University. Retrieved from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540747/all/Coronavirus_COVID_19__SARS_CoV_2_ 

    • Required Learning Resources and Activities
    • Associate clinical signs and additional test results with critical illness

    • Read the section of the article labeled "CLINICAL". You can access this section by opening the link provided and clicking the word "CLINICAL" on the left-hand side of the screen.

    • Read the sections Abstract and Discussion.

    • To access the quiz, click on the name of the quiz provided above. On the following screen, click the "Preview quiz now" button to respond to the questions.

    • Additional Resources for Optional Learning
    • This article provides an overview of the association of markers in routine blood tests with the severity of COVID-19.

      Read the entire article.